Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing
This story is from 2026-11-12. It is preserved in the archive; the latest stories are on the live feed.
Biomatter announced on November 12, 2026, an oversubscribed $18 million Series A led by Astanor, with participation from UVC Partners, Inventure and Metaplanet, to expand its AI enzyme design and testing.
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-11-12 12:03 · Unite.AI
Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing